Parkinson’s disease is a progressive neurodegenerative disease, characterized by the destruction of certain nerve cells in the brain, the accumulation of neurotoxic protein clusters. Thanks to the progress made in recent years, the pathophysiological processes at work have become better understood. Ultimately, these discoveries should lead to the development of treatments capable of stopping or slowing the progression of the disease. But currently, the management of patients is mainly based on the administration of dopamine; in order to compensate for the effects associated with neurodegeneration, as well as drugs that make it possible to alleviate the non-motor symptoms of the disease.
What is Parkinson’s disease or Parkinson’s
Parkinson’s disease is the second most common neurodegenerative disease after Alzheimer’s disease. It is a major cause of disability in the elderly. Very rare before the age of 45, the incidence of Parkinson’s disease increases in older age groups, peaking between the ages of 85 and 89.